Abbott Slumps As Falling Covid Cases Reduce Demand For Tests

© Reuters.

By Dhirendra Tripathi

Investing – Shares of Abbott Laboratories (NYSE:) fell more than 8% Tuesday as a falling number of Covid-19 cases has reduced demand for its testing-related business, forcing it to lower its full-year guidance.

Abbott President and Chief Executive Officer Robert B. Ford said there has been a rapid decline in demand for its testing services, and since they anticipate the trend to continue, they are now revising their guidance.

Full-year diluted earnings per share under GAAP are now seen at $2.75 to $2.95. These were expected to be $3.74 at least as per Abbott’s April 20 forecast.

The company follows a calendar year.

“This (latest forecast) has been driven by several factors, including significant reductions in cases in the U.S. and other major developed countries, accelerated rollout of COVID-19 vaccines globally and, most recently, U.S. health authority guidance on testing for fully vaccinated individuals,” Abbott said in a note.

Global Covid-19 testing brought the company $2.2 billion in sales in the first quarter, about one-fifth of its total sales of $10.45 billion and more than half the $4.01 billion in revenue from diagnostics.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

READ  U.S. sues to force Altria to unwind investment in JUUL

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Please enter your comment!
Please enter your name here